Cargando…
EGFR Signaling in Colorectal Carcinoma
The epidermal growth factor receptor (EGFR) and its downstream signaling pathways are involved in the development and progression of several human tumors, including colorectal cancer. Much attention has been given to the EGFR pathway as of lately because both EGFR and some downstream components serv...
Autor principal: | Krasinskas, Alyssa M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042643/ https://www.ncbi.nlm.nih.gov/pubmed/21403829 http://dx.doi.org/10.4061/2011/932932 |
Ejemplares similares
-
Tubular adenoma with high-grade dysplasia in the ileal segment 34 years after augmentation ileocystoplasty: report of a first case
por: Armah, Henry B, et al.
Publicado: (2007) -
Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
por: Miyamoto, Yuji, et al.
Publicado: (2017) -
Infiltrative Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With a Single High-Dose Y90 Radioembolization and Subsequent Liver Transplantation Without a Recurrence
por: Dendy, Meaghan S., et al.
Publicado: (2017) -
Immune Resistance and EGFR Antagonists in Colorectal Cancer
por: Giordano, Guido, et al.
Publicado: (2019) -
EGFR-TKIs resistance via EGFR-independent signaling pathways
por: Liu, Qian, et al.
Publicado: (2018)